this is because of market sentiment towards biotechs, imo. I think that is all. More healing is needed. + there will not be exceptional news till very late this year. There are other biotech trades to be done in the weeks and months ahead - if you are a fund. Sell now - make some profits somewhere else, and come back later. I'll be hanging around here but others will become impatient.
Summer is coming here in the northeast - one of these days - after a brutal winter. I am not setting in the house trading biotechs. I'm going to be outside enjoying life. And it's a strong buy down here! imo of course.
Jason Napadano predicts that this drug will be a real nice nitch market for TNXP. Jason will only rate the value of a stock with regards to the market it is intended for.
I worked 3rd shift for 13 years professionally as an IT support person. I also worked 3rd shift going through college at UPS - thank you so much UPS for the help. I know a think or two about sleep problems. If the price is right and in the right marketing organization - off label use will be astounding. "If". And I mean "If".
The first If is - how effective will it be in the military population?
And then there's fibromyalgia or something like that. Not sure of the spelling.
The military revenue will not move the needle much. The value here is that it is a well defined and well networked population so they should be able to get enough patients enrolled quickly. The estimated total (all levels of suffering) ptsd market in the U.S. is estimated at 7.7 million people. PTSD is worse where deliberate acts are committed - rape, murder, attempted murder, robbery etc. And if someone is murdered, there is the family to consider.